SCM
GYRE icon

Sio Capital Management’s Gyre Therapeutics GYRE Stock Holding History

Sio Capital Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83,186
Closed -$2.56M – 73
2021
Q3 		$2.56M Hold
83,186
– – 0.82% 36
2021
Q2 		$2.7M Hold
83,186
– – 0.67% 46
2021
Q1 		$3.14M Buy
83,186
+58,024
+231% +$2.65M 0.64% 51
2020
Q4 		$1.19M Sell
25,162
-1,333
-5% -$57.7K 0.24% 77
2020
Q3 		$854K Hold
26,495
– – 0.17% 76
2020
Q2 		$1.17M Sell
26,495
-2,667
-9% -$125K 0.34% 59
2020
Q1 		$956K Buy
29,162
+1,872
+7% +$86K 0.32% 51
2019
Q4 		$1.39M Sell
27,290
-3,334
-11% -$140K 0.33% 49
2019
Q3 		$1.13M Sell
30,624
-37,982
-55% -$2.05M 0.36% 53
2019
Q2 		$3.79M Buy
68,606
+8,032
+13% +$502K 0.91% 41
2019
Q1 		$3.68M Buy
60,574
+21,691
+56% +$1.39M 0.99% 45
2018
Q4 		$2.3M Sell
38,883
-34,581
-47% -$2.55M 0.84% 45
2018
Q3 		$5.94M Buy
73,464
+10,604
+17% +$840K 2.04% 19
2018
Q2 		$5.5M Sell
62,860
-90,472
-59% -$15.9M 3.04% 12
2018
Q1 		$29.7M Buy
153,332
+126,361
+469% +$23.6M 17.83% 1
2017
Q4 		$2.76M Sell
26,971
-29,247
-52% -$1.49M 1.56% 22
2017
Q3 		$2.13M Buy
56,218
+9,128
+19% +$274K 1.11% 34
2017
Q2 		$1.64M Buy
+47,090
New +$1.69M 0.78% 42

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sio Capital Management's GYRE Position: Q4 2021 in Review

Sio Capital Management sold out of Gyre Therapeutics (GYRE) in Q4 2021, closing a stake of 83,186 shares — an estimated $2.56M sold.

Sio Capital Management first reported a position in GYRE in Q2 2017 and held it in 18 quarters. The position peaked at $29.7M in Q1 2018. 51 funds tracked by Wall St. Rank hold GYRE as of Q4 2021.

  • Sio Capital Management reported no remaining Gyre Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Sio Capital Management sold 83,186 Gyre Therapeutics shares in Q4 2021, an estimated $2.56M.
  • Sio Capital Management first reported a position in Gyre Therapeutics in Q2 2017 and held it in 18 quarters.
  • Sio Capital Management's Gyre Therapeutics position peaked at $29.7M in Q1 2018.
  • 51 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.